These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10792230)

  • 21. Progressive outer retinal necrosis in a patient with cutaneous non-Hodgkin's T cell lymphoma (Sézary syndrome).
    Njoo FL; Rothova A; Van Der Lelij A
    Br J Ophthalmol; 1998 Oct; 82(10):1218-9. PubMed ID: 9924317
    [No Abstract]   [Full Text] [Related]  

  • 22. Successfully treated Hodgkin's disease followed by mycosis fungoides: case report and review of the literature.
    Kaufman D; Gordon LI; Variakojis D; Caro WA; Marder R; Jumbelic M; Roenigk HH
    Cutis; 1987 Apr; 39(4):291-6. PubMed ID: 3581901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A; Levy E; Weinborn M; Cuny JF; Schmutz JL; Barbaud A; Cribier B; Bursztejn AC
    Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
    Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
    J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).
    Gautschi O; Blumenthal N; Streit M; Solenthaler M; Hunziker T; Zenhäusern R
    Eur J Haematol; 2004 Jan; 72(1):61-3. PubMed ID: 14962265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mu-Opioid receptor is induced by IL-13 within lymph nodes from patients with Sézary syndrome.
    Bénard A; Cavaillès P; Boué J; Chapey E; Bayry J; Blanpied C; Meyer N; Lamant L; Kaveri SV; Brousset P; Dietrich G
    J Invest Dermatol; 2010 May; 130(5):1337-44. PubMed ID: 20107485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
    Schappell DL; Alper JC; McDonald CJ
    Arch Dermatol; 1995 Mar; 131(3):307-13. PubMed ID: 7887660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexisting mycosis fungoides and Hodgkin's disease as a composite lymphoma: a case report.
    Park CS; Chung HC; Lim HY; Kim DL; Koh EH; Kim JH; Roh JK; Chun SI; Yang WI; Kim GE
    Yonsei Med J; 1991 Dec; 32(4):362-9. PubMed ID: 1812658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.
    Miyashiro D; Souza BCE; Torrealba MP; Manfrere KCG; Sato MN; Sanches JA
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases.
    Algarni AS; Ram-Wolff C; Bagot M; De Masson A
    Eur J Dermatol; 2021 Apr; 31(2):213-216. PubMed ID: 33814357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycosis fungoides with recurrent Hodgkin's lymphoma and diffuse large B-cell lymphoma.
    Miyagaki T; Sugaya M; Minatani Y; Fujita H; Hangaishi A; Kurokawa M; Takazawa Y; Tamaki K
    Acta Derm Venereol; 2009; 89(4):421-2. PubMed ID: 19688163
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.
    Clark RA
    J Invest Dermatol; 2009 Dec; 129(12):2747-50. PubMed ID: 19901946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.
    Nevet MJ; Zuckerman T; Sahar D; Bergman R
    Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
    Shaw MT; Jacobs SR
    Cancer; 1989 Dec; 64(12):2585-7. PubMed ID: 2819668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study on the evolution of the T-cell repertoire in patients with Sézary syndrome treated by extracorporeal photopheresis.
    Ingen-Housz-Oro S; Bussel A; Flageul B; Michel L; Dubertret L; Kourilsky P; Gachelin G; Bachelez H; Musette P
    Blood; 2002 Sep; 100(6):2168-74. PubMed ID: 12200382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
    Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
    J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.
    Scarisbrick JJ; Child FJ; Clift A; Sabroe R; Whittaker SJ; Spittle M; Russell-Jones R
    Br J Dermatol; 2001 May; 144(5):1010-5. PubMed ID: 11359390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sezary syndrome.
    Ali CM; Sikdar TK; Sultana N; Hoque MR; Ahmed N; Parvez Z; Kamal B; Rahman F
    Mymensingh Med J; 2011 Jul; 20(3):497-500. PubMed ID: 21804519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.